BPC 157 (acetate) – 5 mg

Brand:
Cayman
CAS:
1628202-19-6
Storage:
-20
UN-No:
Non-Hazardous - /

Body protection compound 157 (BPC 157) is a pentadecapeptide fragment of BPC that has been found in gastric juice and has diverse biological activities.{53893} It increases cell migration of, and F-actin formation in, primary rat tendon fibroblasts when used at a concentration of 2 µg/ml.{53894} BPC 157 (0.01 and 10 µg/kg, i.p.) reduces paw swelling, bone erosion, and inflamed joint mononuclear cell infiltration in a rat model of rheumatoid arthritis induced by complete Freund’s adjuvant (CFA).{53895} It decreases the lesion size of gastric ulcers induced by indomethacin (Item No. 70270), aspirin (Item No. 70260), or diclofenac (Item Nos. 70680 | 22983) in rats at the same doses. BCP 157 (0.01 and 10 µg/kg, i.p.) decreases the duration of catalepsy and reduces tremor severity in a mouse model of Parkinson’s disease induced by MPTP.{53896}  

 

Available on backorder

SKU: 30989 - 5 mg Category:

Description

A BPC pentadecapeptide fragment with diverse diverse biological activities; increases cell migration of, and F-actin formation in, primary rat tendon fibroblasts at 2 µg/ml; reduces paw swelling, bone erosion, and inflamed joint mononuclear cell infiltration in a rat model of CFA-induced rheumatoid arthritis at 0.01 and 10 µg/kg; decreases the lesion size of indomethacin-, aspirin-, or diclofenac-induced gastric ulcers in rats at 0.01 and 10 µg/kg; decreases the duration of catalepsy and reduces tremor severity in an MPTP-induced mouse model of Parkinson’s disease at 0.01 and 10 µg/kg


Formal name: glycyl-L-α-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-α-aspartyl-L-α-aspartyl-L-alanylglycyl-L-leucyl-L-valine, acetate

Synonyms:  GEPPPGKPADDAGLV|Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular weight: 1,419.50

CAS: 1628202-19-6

Purity: ≥95%

Formulation: A solid